Patent Law Harmonization

I'm writing on  behalf of the Biotechnology Industry Organization (BIO) in response to your invitation for public comments on questions pertaining to international efforts t0 harmonize substantive requirements of patient laws, dated May 3, 2007 (72 FR 24566). BIO is a trade association representing more than 1100 companies and entities focused on research, development commercialization of inventions in the field of Biotechnology.